Lupin's revenues decreased by 5.7% YoY to Rs 31.5 bn in Q1FY16 lower than our estimates of Rs 33.4 bn on back of de-growth in US business. Operating margins declined by 750bps YoY to 25.9% (lower than our estimate of 26.9%) due to revenue de-growth, higher R&D, other expenses and staff cost.